Vanguard Group Inc Agios Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,682,019 shares of AGIO stock, worth $201 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,682,019
Previous 5,604,591
1.38%
Holding current value
$201 Million
Previous $164 Million
15.08%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AGIO
# of Institutions
234Shares Held
61.8MCall Options Held
288KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$204 Million0.86% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$127 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$82.3 Million0.65% of portfolio
-
Commodore Capital LP New York, NY2.33MShares$82.3 Million7.21% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...